Phlebotomy Tubes Market By Type (Glass Phlebotomy Tubes, Plastic Phlebotomy Tubes), By Additive Type (EDTA, Heparin, Sodium Citrate, Lithium Heparin, Gel Separator), By Application (Blood Collection, Blood Culture Testing, Clinical Chemistry, Hematology, Immunology), By End-Use Industry (Hospitals, Diagnostic Laboratories, Blood Banks, Clinics and Healthcare Centers, Research Institutes), By Capacity (Low Volume, Medium Volume, High Volume); Global Insights & Forecast (2024 - 2030)

As per Intent Market Research, the Phlebotomy Tubes Market was valued at USD 2.1 Billion in 2024-e and will surpass USD 3.4 Billion by 2030; growing at a CAGR of 8.4% during 2025-2030.

The phlebotomy tubes market plays a critical role in the healthcare industry, specifically in diagnostic and laboratory testing. These tubes are designed to collect blood samples for various diagnostic procedures, making them a vital component in medical facilities worldwide. The increasing demand for blood tests due to growing health awareness, an aging population, and the rising prevalence of chronic diseases are key drivers fueling the market growth. Additionally, advances in diagnostic techniques and the increasing number of clinical laboratories further support the market's expansion. Phlebotomy tubes are used across several applications, including clinical chemistry, immunology, hematology, and blood culture testing, all of which require highly reliable and contamination-free blood collection methods.

As technology advances, the demand for specialized phlebotomy tubes with various additives is growing, allowing for more accurate and faster diagnostic results. The key trends influencing the market include increasing focus on blood collection efficiency, minimizing errors in diagnostics, and developing more advanced, user-friendly, and cost-effective products for various diagnostic purposes. Manufacturers are increasingly focusing on improving the design and functionality of phlebotomy tubes, introducing innovations such as gel separators and tubes with different additive compositions to cater to diverse applications in the clinical setting.

Plastic Phlebotomy Tubes Are Dominant in the Market

Plastic phlebotomy tubes represent the largest subsegment in the market, primarily due to their cost-effectiveness, durability, and ease of handling compared to glass tubes. Plastic tubes offer a significant advantage in terms of reduced risk of breakage, making them a preferred choice for many healthcare providers. Additionally, plastic tubes are often lighter than their glass counterparts, making them more convenient for storage and transportation. As healthcare facilities worldwide move towards more cost-effective and efficient options, plastic phlebotomy tubes are increasingly favored for both high-volume and low-volume blood collection applications.

Another important factor contributing to the dominance of plastic phlebotomy tubes is their versatility in a wide range of applications. These tubes are commonly used for blood collection in clinical chemistry, hematology, and immunology due to their ability to retain and stabilize blood samples with additives. The growing demand for blood testing in hospitals and diagnostic laboratories, as well as the increasing use of automated systems for blood sample processing, is further fueling the preference for plastic over glass tubes. The development of new plastic-based formulations that provide better blood sample stability and improve diagnostic accuracy is also expected to drive further adoption in the coming years.

EDTA (Ethylenediaminetetraacetic Acid) Additives Lead the Additive Type Market

EDTA (Ethylenediaminetetraacetic acid) is the leading additive used in phlebotomy tubes, particularly for blood collection applications in hematology. EDTA is a powerful anticoagulant that prevents blood from clotting, making it an essential ingredient in tubes used for blood cell analysis. The global demand for EDTA-based tubes is growing, driven by the increasing number of blood tests in healthcare settings and their critical role in the diagnosis of blood-related disorders. EDTA additives ensure that blood samples can be processed accurately and quickly, making them ideal for diagnostic testing, particularly in the examination of blood cells.

In addition, EDTA has the advantage of being compatible with a broad range of diagnostic tests, which has helped it maintain its dominant position in the phlebotomy tube market. With the growing focus on early detection of diseases and disorders, particularly in oncology, hematology, and autoimmune diseases, the use of EDTA-based tubes is expected to rise. The ability to obtain accurate test results without compromising sample integrity makes EDTA a top choice for healthcare providers. As the medical industry continues to focus on improving diagnostic accuracy, the demand for EDTA-based phlebotomy tubes is expected to see robust growth.

Blood Collection Segment Drives Demand for Phlebotomy Tubes

The blood collection segment is the largest application area for phlebotomy tubes, accounting for a substantial share of the market. Blood collection is the first and most critical step in a wide range of diagnostic tests, which drives the consistent demand for phlebotomy tubes. Hospitals, clinics, and diagnostic laboratories rely heavily on phlebotomy tubes to ensure that samples are collected efficiently, safely, and without contamination. With the increasing demand for routine blood tests and specialized diagnostic tests across various medical specialties, the blood collection application is projected to maintain its dominant market position.

The rise in chronic diseases, such as diabetes, cardiovascular diseases, and cancer, has led to a surge in blood testing procedures, further propelling the blood collection segment's growth. Additionally, the increasing trend of preventive healthcare and the focus on early disease detection contribute to the growing demand for blood collection services. As healthcare systems globally expand and modernize, blood collection remains a key component, driving the need for high-quality, reliable phlebotomy tubes.

Hospitals and Diagnostic Laboratories Are Leading End-Users

Hospitals and diagnostic laboratories are the leading end-users in the phlebotomy tubes market, representing a large portion of the total demand. Hospitals, with their extensive diagnostic and emergency care services, require a constant supply of phlebotomy tubes for a variety of purposes, including routine blood tests, urgent diagnostics, and critical care. Diagnostic laboratories, which specialize in testing and analysis, rely heavily on phlebotomy tubes to ensure that blood samples are collected, processed, and analyzed efficiently. The demand from these end-users is driven by the increasing number of diagnostic tests and growing patient numbers globally.

As hospitals and diagnostic laboratories expand, particularly in emerging markets, the need for reliable and cost-effective phlebotomy tubes is expected to continue to rise. The ongoing development of new diagnostic technologies and an increase in testing volumes for both chronic and infectious diseases further support the demand from these sectors. Additionally, the growing adoption of automation in medical laboratories enhances the efficiency of blood sample processing, driving demand for standardized and high-quality phlebotomy tubes.

North America to Maintain Dominance in the Phlebotomy Tubes Market

North America is expected to remain the largest region in the phlebotomy tubes market, primarily due to the high demand for diagnostic tests in the healthcare sector. The United States, with its advanced healthcare infrastructure and a well-established market for diagnostic services, contributes significantly to the region's dominance. The high prevalence of chronic diseases, coupled with the aging population in North America, is driving the demand for blood testing services. Additionally, North America's focus on early disease detection and preventive healthcare is pushing the adoption of high-quality diagnostic equipment, including phlebotomy tubes.

The region is also home to several major manufacturers of medical diagnostic products, providing a competitive edge to the market. The continuous advancements in healthcare technologies, along with increasing investments in research and development, are expected to bolster the growth of the phlebotomy tubes market in North America. As the demand for diagnostic testing rises, particularly in hospitals and diagnostic laboratories, North America will continue to lead the phlebotomy tubes market.

Competitive Landscape: Key Players and Market Strategies

The phlebotomy tubes market is competitive, with key players focusing on product innovation, quality, and cost-effectiveness to cater to the growing demand from hospitals, diagnostic laboratories, and clinics. Leading companies in the market include Becton Dickinson and Company, Terumo Corporation, Greiner Bio-One International GmbH, and Copan Italia S.p.A. These companies are continuously working on improving the design and functionality of their phlebotomy tubes, introducing products with specialized additives and advanced features such as gel separators.

The competitive landscape is also marked by strategic acquisitions, partnerships, and collaborations aimed at expanding product portfolios and entering new markets. Manufacturers are investing heavily in R&D to introduce more advanced phlebotomy tube options that offer better performance, accuracy, and convenience. The growing emphasis on automation in medical diagnostics is also driving the demand for phlebotomy tubes that can be easily integrated into automated systems, which is becoming a key focus for market players.

Recent Developments:

• Thermo Fisher Scientific expanded its line of blood collection tubes with new, advanced plastic tubes designed for clinical diagnostics.
• BD (Becton, Dickinson and Company) launched a new range of phlebotomy tubes designed for faster, more efficient blood collection and sample processing.
• Greiner Bio-One International GmbH announced the development of an innovative gel separator technology for enhanced blood sample separation.
• Medtronic partnered with hospitals to provide new phlebotomy tube solutions that improve diagnostic accuracy and safety.
• Cardinal Health, Inc. expanded its distribution network for phlebotomy tubes, focusing on emerging markets to enhance availability.

List of Leading Companies:

• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Greiner Bio-One International GmbH
• Sarstedt AG & Co.
• Cardinal Health, Inc.
• Sekisui Diagnostics, LLC
• Medtronic
• FL Medical
• Kawasumi Laboratories, Inc.
• Meridian Bioscience, Inc.
• Shanghai Medical Corporation
• Shanghai Yian Medical Devices Co., Ltd.
• Neomedic Limited
• MICSAP Medical
• Hainan Zhongtai Medical Instruments Co., Ltd.

Report Scope: